John Lewis: Metastatic Cancer, Entos Pharmaceutical, Nucleic acid platform |Learning with Lowell 192
- June 9, 2023
- Tagged as: acquisition, Discovering unknown cancers, Diverse populations for clinical research, Early detection, etc, FDA organ on a chip, Future vision of companies - IPO, Innovation and great science, Keeping investors happy, Licensing in biotech, Metastatic cancer treatment, mRNA vs DNA based vaccine, Next generation nucleic acid platform, Open source biotech / technology, Orally bioavailable genetic medicine, Political instability preventing clinical trials, Rare skill sets, Strategy for hiring / question asking, Targeting cancer and biophysics nanoparticles
Podcast: Play in new window | Download (Duration: 1:25:42 — 117.7MB) | Embed
Subscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Podcast Index | TuneIn | RSS | More
https://media.blubrry.com/learningwithlowell/www.learningwithlowell.com/wp-content/uploads/2023/06/John-lewis-and-the-jets.mp3Podcast: Play in new window | Download (Duration: 1:25:42 — 117.7MB) | EmbedSubscribe: Apple Podcasts | Spotify | Amazon Music | Android | Pandora | iHeartRadio | Podcast Index | TuneIn | RSS | MoreDr….